Study of Genistein in Reducing Side Effects of Superficial Bladder Cancer Treatment
Status:
Recruiting
Trial end date:
2024-05-01
Target enrollment:
Participant gender:
Summary
Patients with non-invasive bladder cancer are often treated with intravesical therapy in
order to prevent the recurrence of bladder cancer. Intravesical therapy can cause many lower
urinary tract symptoms, which can limit the dose of therapy and therefore efficacy of
treatment. There have been a number of studies that suggest a chemical found in soy beans may
be able to help with these side effects. This chemical is called genistein and can be
extracted and given to study subjects in pill form. In this study, the investigators would
like to have patients placed into two different groups. One group would take genistein and
the other group would take a placebo, a sugar pill that looks like the genistein pill. In
doing this study the investigators hope to explore the findings from other studies to see if
lower urinary tract symptoms are reduced and to see if recurrence rates for patients are
affected by genistein. The study would take about four and a half months total.